| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |